LTBI among migrants by Mediterranean Sea: assessing prevalence and its variations according with different thresholds and diagnostic tools. A 10-month on-field experience
Author(s) -
Chiara Bertoncello,
António Ferro,
Anna Ferraresso,
Marta Mascarello,
Marco Fonzo,
V Minascurta,
Ilaria Pistellato,
C Cabbia,
Silvia Cocchio,
Tatjana Baldovin,
Vincenzo Baldo
Publication year - 2018
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/tay020
Subject(s) - medicine , tuberculin , latent tuberculosis , tuberculosis , vaccination , interferon gamma release assay , incidence (geometry) , demography , environmental health , immunology , mycobacterium tuberculosis , pathology , physics , optics , sociology
In 2016, 362 753 migrants reached Europe by sea. Most of migrants come from high tuberculosis (TB) burden countries and travel in conditions that increase the risk for communicable diseases. The goal of WHO End TB Strategy is to end global epidemic by 2035. Management of latent TB infection (LTBI) in low TB incidence countries is thus essential. Nevertheless, a lack of uniformity in policies and procedures for LTBI screening in Europe is perceived. The aim of this study was to estimate the LTBI prevalence in migrants by Mediterranean Sea.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom